8-K: XWELL Receives Nasdaq Delisting Warning

XWELL, Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day compliance period.

Summary

• XWELL, Inc. received a letter from the Nasdaq Stock Market on December 1, 2025, indicating non-compliance with the minimum bid price requirement.
• The company's common stock closing bid price was below $1.00 per share for 30 consecutive business days, from October 17, 2025, to November 28, 2025, violating Nasdaq Listing Rule 5550(a)(2).
• XWELL has been granted a compliance period of 180 calendar days, until June 1, 2026, to regain compliance.
• To regain compliance, the common stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the compliance period.
• The notice has no immediate impact on the listing of the company's common stock, which will continue to be listed and traded on Nasdaq, subject to compliance with other listing requirements.

Sentiment

Score: 3

Explanation: The company received a delisting notice from Nasdaq due to its stock price falling below the minimum bid requirement, indicating significant market underperformance and creating uncertainty regarding its continued listing. While a compliance period is granted, the underlying issue and potential for delisting are negative.

Negatives

• The company's common stock failed to meet Nasdaq's minimum $1.00 bid price requirement for 30 consecutive business days.
• Receipt of a delisting notice from Nasdaq indicates significant market underperformance and potential risk to the company's listing status.

Risks

• Potential delisting of the company's common stock from The Nasdaq Capital Market if compliance is not regained.
• Uncertainty regarding eligibility for an additional 180-calendar day compliance period if initial compliance is not met.
• The need for a reverse stock split, if necessary, to cure the bid price deficiency, which can be dilutive or negatively perceived by the market.
• Nasdaq staff may determine the company is unable to cure the deficiency, leading to delisting without an additional cure period.

Future Outlook

The company has a 180-day period to regain compliance with Nasdaq's minimum bid price requirement. There is a possibility of an additional 180-day compliance period if certain conditions are met, including meeting market value requirements and potentially effecting a reverse stock split. However, there is no assurance that the company will be eligible for or granted such an extension.

Management Comments

• The company acknowledges the receipt of the Nasdaq notice and the initiation of the compliance period, as evidenced by the filing of this 8-K and the signature of its President and CEO, Ezra T. Ernst.

Industry Context

Receiving a minimum bid price deficiency notice is a common occurrence for smaller capitalization companies, particularly those facing operational challenges or in periods of broader market volatility. It often signals investor concern about the company's financial health or growth prospects, leading to depressed stock prices. Companies in this situation typically explore options such as operational improvements, investor relations efforts, or corporate actions like reverse stock splits to address the issue.

Stakeholder Impact

• Shareholders face increased uncertainty regarding the company's continued listing on Nasdaq, which could impact the liquidity and market value of their shares.
• Potential delisting could lead to the stock trading on over-the-counter markets, which typically have lower liquidity and transparency.

Next Steps

• Regain compliance with Nasdaq's minimum bid price requirement by maintaining a closing bid price of $1.00 or more for at least ten consecutive business days by June 1, 2026.
• If compliance is not regained, assess eligibility for an additional 180-day compliance period by meeting market value and other initial listing standards, and providing written notice of intent to cure, potentially through a reverse stock split.
• In the event of a delisting notification, the company may appeal Nasdaq's determination.

Key Dates

Recommendation

The company's failure to meet Nasdaq's minimum bid price requirement signals significant underperformance and introduces substantial delisting risk. While a compliance period is granted, the need for a potential reverse stock split or the risk of eventual delisting creates considerable uncertainty and could negatively impact liquidity and shareholder value. Investors should consider selling to mitigate further downside risk.

Keywords

XWELL, XWEL, Nasdaq, Delisting, Minimum Bid Price, Compliance, Stock Market, SEC Filing, 8-K